Interaction of Alt a 1 with SLC22A17 in the airway mucosa. Issue 11 (24th June 2019)

• Record Type: Journal Article
• Authors: Garrido‐Arandia, María; Tome‐Amat, Jaime; Pazos‐Castro, Diego; Esteban, Vanesa; Escribese, Maria M.; Hernández‐Ramírez, Guadalupe; Yuste‐Montalvo, Alma; Barber, Domingo; Pacios, Luis F.; Díaz‐Perales, Araceli
• Is Part Of: Allergy. Volume 74:Issue 11(2019)
• Page Start: 2167
• Page End: 2180
• Publication Date: 2019-06-24
• Subjects: Alt a 1 -- Alternaria alternata -- fungal allergen -- human airway epithelium -- solute carrier family 22 member 17 receptor; Allergy -- Periodicals; 616.97
• DOI: 10.1111/all.13877
• Languages: English
• ISSNs: 0105-4538

Abstract

Abstract: Background: Despite all the efforts made up to now, the reasons that facilitate a protein becoming an allergen have not been elucidated yet. Alt a 1 protein is the major fungal allergen responsible for chronic asthma, but little is known about its immunological activity. Our main purpose was to investigate the ligand‐dependent interactions of Alt a 1 in the human airway epithelium. Methods: Alt a 1 with and without its ligand (holo‐ and apo‐ forms) was incubated with the pulmonary epithelial monolayer model, Calu‐3 cells. Allergen transport and cytokine production were measured. Pull‐down and immunofluorescence assays were employed to identify the receptor of Alt a 1 using the epithelial cell model and mouse tissues. Receptor‐allergen‐ligand interactions were analyzed by computational modeling. Results: The holo‐form could activate human monocytes, PBMCs, and polarized airway epithelial (Calu‐3) cell lines. The allergen was also transported through the monolayer, without any alteration of the epithelial integrity (TEER). Alt a 1 also induced the production of proinflammatory IL8 and specific epithelial cytokines (IL33 and IL25) by Calu‐3 cells. The interaction between epithelial cells and holo‐Alt a 1 was found to be mediated by the SLC22A17 receptor, and its recognition of Alt a 1 was explained in structural terms. Conclusions: Our findings identified the Alt a 1 ligand as a central player in the interaction of the allergen with airway mucosa, shedding light into its potential role in the immunological response, while unveiling its potential as a new target for therapy intervention. Abstract : Alt a 1 is released from Alternaria alternata spores in complex with its native ligand, being recognized by the Solute carrier family 22 member 17 receptor. Production of cytokines IL25 and IL33 occurs only in the presence of the ligand, being abolished with specific antibodies against Solute carrier family 22 member 17. Alt a 1 shows structural relationship with human siderocalin mimicking its airway entry route.